NO20056070L - Anti artrittkombinasjoner - Google Patents

Anti artrittkombinasjoner

Info

Publication number
NO20056070L
NO20056070L NO20056070A NO20056070A NO20056070L NO 20056070 L NO20056070 L NO 20056070L NO 20056070 A NO20056070 A NO 20056070A NO 20056070 A NO20056070 A NO 20056070A NO 20056070 L NO20056070 L NO 20056070L
Authority
NO
Norway
Prior art keywords
combinations
arthritis
anti arthritis
inhibition
therapy
Prior art date
Application number
NO20056070A
Other languages
English (en)
Norwegian (no)
Inventor
Heather Anne Harris
Damien P Quinn
Regina H Kurrasch
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20056070L publication Critical patent/NO20056070L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20056070A 2003-05-21 2005-12-20 Anti artrittkombinasjoner NO20056070L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47238203P 2003-05-21 2003-05-21
PCT/US2004/016030 WO2004103365A1 (en) 2003-05-21 2004-05-20 Antiarthritic combinations

Publications (1)

Publication Number Publication Date
NO20056070L true NO20056070L (no) 2006-02-14

Family

ID=33476949

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056070A NO20056070L (no) 2003-05-21 2005-12-20 Anti artrittkombinasjoner

Country Status (17)

Country Link
US (1) US20040248865A1 (pt)
EP (1) EP1631283A1 (pt)
JP (1) JP2007500223A (pt)
KR (1) KR20060013666A (pt)
CN (1) CN1791404A (pt)
AR (1) AR044428A1 (pt)
AU (1) AU2004240668A1 (pt)
BR (1) BRPI0411145A (pt)
CA (1) CA2524116A1 (pt)
CL (1) CL2004001186A1 (pt)
EC (1) ECSP056177A (pt)
MX (1) MXPA05012562A (pt)
NO (1) NO20056070L (pt)
RU (1) RU2005140041A (pt)
TW (1) TW200500065A (pt)
WO (1) WO2004103365A1 (pt)
ZA (1) ZA200509376B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1819322A2 (en) * 2004-12-02 2007-08-22 Wyeth a Corporation of the State of Delaware Formulations of substituted benzoxazoles
US20060210644A1 (en) * 2004-12-16 2006-09-21 Bruce Levin Materials, methods, and devices for treatment of arthropathies and spondylopathies
US20090018121A1 (en) * 2005-03-29 2009-01-15 Kowa Co., Ltd. Preventive and/or therapeutic agent for rheumatoid arthritis
AR059574A1 (es) * 2006-02-14 2008-04-16 Wyeth Corp Formulaciones farmaceuticas acuosas de ligandos selectivos er-beta
RU2367430C1 (ru) * 2008-04-16 2009-09-20 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Способ прогноза эффективности лечения ревматоидного артрита симвастатином
CA2721920A1 (en) 2008-04-22 2009-10-29 Toyama Chemical Co., Ltd. Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components
EP2432480B1 (en) * 2009-05-18 2021-05-05 The University of Hong Kong Compositions and methods for treating inflammatory arthritis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
IL141724A0 (en) * 1998-08-28 2002-03-10 Scios Inc INHIBITORS OF P38-α KINASE
US6080580A (en) * 1998-10-05 2000-06-27 Isis Pharmaceuticals Inc. Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression
US6225311B1 (en) * 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
US6541477B2 (en) * 1999-08-27 2003-04-01 Scios, Inc. Inhibitors of p38-a kinase
AU2002221239A1 (en) * 2000-12-07 2002-06-18 Astrazeneca Ab Therapeutic benzimidazole compounds
US6589980B2 (en) * 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
US6914074B2 (en) * 2001-12-13 2005-07-05 Wyeth Substituted phenyl naphthalenes as estrogenic agents

Also Published As

Publication number Publication date
CA2524116A1 (en) 2004-12-02
AR044428A1 (es) 2005-09-14
CL2004001186A1 (es) 2005-04-15
US20040248865A1 (en) 2004-12-09
KR20060013666A (ko) 2006-02-13
RU2005140041A (ru) 2006-05-10
ZA200509376B (en) 2007-04-25
TW200500065A (en) 2005-01-01
BRPI0411145A (pt) 2006-07-11
JP2007500223A (ja) 2007-01-11
EP1631283A1 (en) 2006-03-08
MXPA05012562A (es) 2006-04-18
CN1791404A (zh) 2006-06-21
WO2004103365A1 (en) 2004-12-02
AU2004240668A1 (en) 2004-12-02
ECSP056177A (es) 2006-04-19

Similar Documents

Publication Publication Date Title
NO20071926L (no) Anvendelse av en mTOR-inhibitor i behandling av uterint leioyom.
EA200801301A1 (ru) ИНГИБИТОРЫ АКТИВНОСТИ Akt
TW200612918A (en) Lonidamine analogs
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
DK1894564T3 (da) Anvendelse af en IBAT inhibitor til behandling eller profylakse af konstipation
CL2007002261A1 (es) Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer.
PL2269458T3 (pl) Mieszaniny zawierające strobiluryny i modulatory etylenu
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
ATE448232T1 (de) Substituierte heterozyklen
DE50307886D1 (de) Leitungsführungseinheit zur aktiven führung von leitungen, kabeln oder dergleichen
PL1713503T3 (pl) Hamowanie czynnika B, alternatywny szlak dopełniacza i związane z tym sposoby
NL1025873A1 (nl) Doseringsvormen en wijzen van behandeling met vegfr-remmers.
FI20030893L (fi) Näppäimistö ja menetelmä sen valmistamiseksi
EP1863769A4 (en) HSP90 INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR APPLICATIONS
FR2886851B1 (fr) Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
NO20056070L (no) Anti artrittkombinasjoner
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
EP1656671A4 (en) Spin coating apparatus and coated substrate manufactured using the same
CA112200S (en) Escutcheon for shower / bath control
DE60310092D1 (de) Gelförmiges wasch- und/oder vorbehandlungsmittel
WO2007059226A3 (en) Photoactivatable antimicrobial agents
HUP0203153A2 (hu) Kombinációs kemoterápia
BRPI0507463A (pt) uso de glufosfamide e gemcitabine , produto, e, combinação de glufosfamide e gemcitabine
IL173188A0 (en) Use of alcohol-oxyalkyates in the form of adjuvants for benzamidoxime gungicidal derivatives, appropriate agents and kits

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application